COMMUNIQUÉS West-GlobeNewswire

Inventiva annonce le lancement d'une offre au public
12/11/2025
Daix (France), New York City (New York, États-Unis ), 12 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva announces launch of public offering
12/11/2025
Daix (France), New York City (New York, United States), November 12, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]
Solana Company to Release Third Quarter Operating Results on November 18, 2025
12/11/2025
NEWTOWN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to [...]
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
12/11/2025
DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
12/11/2025
Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine months compared to the [...]
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
12/11/2025
Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine months compared to the [...]
BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results
12/11/2025
SUNNYVALE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported [...]
Natural Alternatives International, Inc. Announces 2026 Q1 Results
12/11/2025
CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
Collegium to Participate in Upcoming Investor Conferences
12/11/2025
STOUGHTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Jefferies London Healthcare [...]
Essity et sa marque JOBST® font équipe avec les Raptors de Toronto pour prouver que « Les armures ne sont pas toutes faites d'acier »
12/11/2025
TORONTO, 12 nov. 2025 (GLOBE NEWSWIRE) -- Essity, chef de file mondial des solutions de compression, et sa marque JOBST® sont ravis d'annoncer un nouveau partenariat stratégique avec les Raptors de Toronto , l'équipe de [...]
Essity Brand, JOBST®, Teams Up with Toronto Raptors to Prove that “Not All Armour is Made of Steel”
12/11/2025
TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Essity brand, JOBST®, a global leader in compression solutions, is thrilled to announce a strategic new partnership with the Toronto Raptors , Canada’s premier basketball team [...]
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
12/11/2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, [...]
Beacon Therapeutics to Participate in the Jefferies Global Healthcare Conference
12/11/2025
LONDON and CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and [...]
Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City
12/11/2025
TUCSON, Ariz., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved [...]
Evaxion announce 2026 financial calendar
12/11/2025
COPENHAGEN, Denmark, November 12, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces its financial calendar for 2026 as [...]
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
12/11/2025
BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]
Standard Dental Labs Inc.: Investor Education Series — Part 2
12/11/2025
From Workbench to Workflow: Digitizing Craftsmanship at Scale Digitizing craftsmanship—at scale. ORLANDO, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) today published Part 2 of its [...]
X9, Inc. Announces Successful Completion of First-in-Human Feasibility Study for Ultrasound-Guided, Power-Assisted Needle Insertion Device in Hemodialysis Cannulation
12/11/2025
WALLINGFORD, Conn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- X9, Inc. today announced positive results from its first-in-human clinical feasibility study evaluating the X9 Ultrasound System with Power-Assisted Needle Insertion [...]
FDA Clears Magstim Magnetic Stimulation for Chronic Pain Treatment
12/11/2025
Landmark clearance opens access to non-drug, non-invasive pain relief for millions MINNEAPOLIS, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Millions of people living with chronic pain now have a clinically proven, non-invasive, [...]

Pages